Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Sep;18(9):756-63.
doi: 10.1016/j.hpb.2016.06.010. Epub 2016 Jul 9.

Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors

Iswanto Sucandy  1 , Susannah Cheek  2 , Benjamin J Golas  3 , Allan Tsung  2 , David A Geller  2 , James W Marsh  2
Affiliations
Comparative Study

Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors

Iswanto Sucandy et al. HPB (Oxford). 2016 Sep.

Abstract

Background: We aim to investigate long-term survival outcomes in patients undergoing radiofrequency ablation (RFA), based on our longitudinal 5 and 10 year follow-up data.

Methods: All patients who underwent RFA for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CLM) between 1999 and 2010.

Results: 320 patients were included with oncologic diagnoses of HCC in 122 (38.1%) and CLM in 198 (61.9%). The majority of patients had a single tumor ablation (71% RFA 1 lesion). Minimum 5 year follow-up information was available in 89% patients, with a median follow-up of 115.3 months. In patients with HCC, disease eventually recurred in 73 (64%) patients. In patients with CLM, disease recurrence was ultimately seen in 143 (84.1%) patients. In the HCC group, the 5- and 10-year overall survivals were 38.5% and 23.4%, while in the CLM group, the 5- and 10-year overall survivals were 27.6% and 15%, respectively.

Conclusions: The use of RFA as a part of treatment strategy for primary and metastatic liver tumors imparts 10-year overall survivals of >23% and 15%, respectively. This study indicates that long-term survival is possible with RFA treatment.

PubMed Disclaimer

Figures

Graph 1
Graph 1
Disease free survivals after RFA
Graph 2
Graph 2
Overall survivals after RFA
See this image and copyright information in PMC

References

    1. Gillams A.R., Lees W.R. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009 May;19:1206–1213. - PubMed
    1. Ardito F., Vellone M., Cassano A., De Rose A.M., Pozzo C., Coppola A. Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival. J Gastrointest Surg. 2013 Feb;17:352–359. - PubMed
    1. Siperstein A.E., Berber E., Ballem N., Parikh R.T. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007 Oct;246:559–565. discussion 565–567. - PubMed
    1. Biasco G., Derenzini E., Grazi G., Ercolani G., Ravaioli M., Pantaleo M.A. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev. 2006 May;32:214–228. - PubMed
    1. Saltz L.B. Metastatic colorectal cancer: is there one standard approach? Oncology (Williston Park) 2005 Aug;19:1147–1154. discussion 1154, 1157–1158, 1160. - PubMed

Publication types

MeSH terms